IL33 and non-small cell lung carcinoma: In essence, pulmonary infection with gram-negative bacteria in NSCLC patients results in TLR4 activation and IL-33 overexpression, promoting tumor progression and recurrence by enhancing cancer metabolic reprograming and cancer stem cell properties.